f C-Reactive Protein Velocity in Patients with ST-elevation Myocardial Infarction: Rethinking a Traditional Biomarker

References

1. Amezcua-Castillo E. González-Pacheco H. Sáenz-San Martín A. Méndez-Ocampo P. Gutierrez-Moctezuma I. Massó F. Sierra-Lara D. Springall R. Rodríguez E. Arias-Mendoza A. Amezcua-Guerra L.M. C-reactive protein: The quintessential marker of systemic inflammation in coronary artery disease—advancing toward precision medicine. Biomedicines 2023 11 9 2444 10.3390/biomedicines11092444 37760885
   [Google Scholar]
2. Suleiman M. Khatib R. Agmon Y. Mahamid R. Boulos M. Kapeliovich M. Levy Y. Beyar R. Markiewicz W. Hammerman H. Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J. Am. Coll. Cardiol. 2006 47 5 962 968 10.1016/j.jacc.2005.10.055 16516078
   [Google Scholar]
3. Black S. Kushner I. Samols D. C-reactive protein. J. Biol. Chem. 2004 279 47 48487 48490 10.1074/jbc.R400025200 15337754
   [Google Scholar]
4. Levinson T. Wasserman A. C-reactive protein velocity (CRPv) as a new biomarker for the early detection of acute infection/inflammation. Int. J. Mol. Sci. 2022 23 15 8100 10.3390/ijms23158100 35897672
   [Google Scholar]
5. Milwidsky A. Ziv-Baran T. Letourneau-Shesaf S. Keren G. Taieb P. Berliner S. Shacham Y. CRP velocity and short-term mortality in ST segment elevation myocardial infarction. Biomarkers 2017 22 3-4 383 386 10.1080/1354750X.2017.1279218 28055283
   [Google Scholar]
6. Holzknecht M. Tiller C. Reindl M. Lechner I. Fink P. Lunger P. Mayr A. Henninger B. Brenner C. Klug G. Bauer A. Metzler B. Reinstadler S.J. Association of C-reactive protein velocity with early left ventricular dysfunction in patients with first st-elevation myocardial infarction. J. Clin. Med. 2021 10 23 5494 10.3390/jcm10235494 34884196
   [Google Scholar]
7. Holzknecht M. Tiller C. Reindl M. Lechner I. Troger F. Hosp M. Mayr A. Brenner C. Klug G. Bauer A. Metzler B. Reinstadler S.J. C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction. Int. J. Cardiol. 2021 338 30 36 10.1016/j.ijcard.2021.06.023 34147553
   [Google Scholar]
8. Zahler D. Merdler I. Rozenfeld K.L. Shenberg G. Milwidsky A. Berliner S. Banai S. Arbel Y. Shacham Y. C-reactive protein velocity and the risk of new onset atrial fibrillation among ST elevation myocardial infarction patients. Isr. Med. Assoc. J. 2021 23 3 169 173 33734630
   [Google Scholar]
9. Zahler D. Rozenfeld K.L. Stein M. Milwidsky A. Berliner S. Banai S. Arbel Y. Shacham Y. C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention. J. Nephrol. 2019 32 3 437 443 10.1007/s40620‑019‑00594‑2 30706372
   [Google Scholar]